TAT transduction: the molecular mechanism and therapeutic prospects

Fawell, 1994, Tat-mediated delivery of heterologous proteins into cells, Proc. Natl. Acad. Sci. U. S. A., 91, 664, 10.1073/pnas.91.2.664 Mann, 1991, Endocytosis and targeting of exogenous HIV-1 Tat protein, EMBO J., 10, 1733, 10.1002/j.1460-2075.1991.tb07697.x Vives, 1997, A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem., 272, 16010, 10.1074/jbc.272.25.16010 Josephson, 1999, High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates, Bioconjug. Chem., 10, 186, 10.1021/bc980125h Pittet, 2006, Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles, Nat. Protoc., 1, 73, 10.1038/nprot.2006.11 Snyder, 2005, Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo, Expert Opin. Drug Deliv., 2, 43, 10.1517/17425247.2.1.43 Wadia, 2005, Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer, Adv. Drug Deliv. Rev., 57, 579, 10.1016/j.addr.2004.10.005 Eguchi, 2001, Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells, J. Biol. Chem., 276, 26204, 10.1074/jbc.M010625200 Glover, 2005, Towards safe, non-viral therapeutic gene expression in humans, Nat. Rev. Genet., 6, 299, 10.1038/nrg1577 Fischer, 2005, Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides, ChemBioChem, 6, 2126, 10.1002/cbic.200500044 Meade, 2007, Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides, Adv. Drug Deliv. Rev., 59, 134, 10.1016/j.addr.2007.03.004 Tunnemann, 2006, Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells, FASEB J., 20, 1775, 10.1096/fj.05-5523com El-Andaloussi, 2005, Cell-penetrating peptides: mechanisms and applications, Curr. Pharm. Des., 11, 3597, 10.2174/138161205774580796 Fotin-Mleczek, 2005, Endocytosis and cationic cell-penetrating peptides–a merger of concepts and methods, Curr. Pharm. Des., 11, 3613, 10.2174/138161205774580778 Gupta, 2005, Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides, Adv. Drug Deliv. Rev., 57, 637, 10.1016/j.addr.2004.10.007 Nakase, 2004, Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement, Mol. Ther., 10, 1011, 10.1016/j.ymthe.2004.08.010 Wadia, 2004, Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis, Nat. Med., 10, 310, 10.1038/nm996 Wender, 2000, The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters, Proc. Natl. Acad. Sci. U. S. A., 97, 13003, 10.1073/pnas.97.24.13003 Rothbard, 2004, Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells, J. Am. Chem. Soc., 126, 9506, 10.1021/ja0482536 Hakansson, 2001, Heparin binding by the HIV-1 tat protein transduction domain, Protein Sci., 10, 2138, 10.1110/ps.23401 Rusnati, 1997, Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size, J. Biol. Chem., 272, 11313, 10.1074/jbc.272.17.11313 Silhol, 2002, Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat, Eur. J. Biochem., 269, 494, 10.1046/j.0014-2956.2001.02671.x Violini, 2002, Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate, Biochemistry, 41, 12652, 10.1021/bi026097e Derossi, 1996, Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent, J. Biol. Chem., 271, 18188, 10.1074/jbc.271.30.18188 Tyagi, 2001, Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans, J. Biol. Chem., 276, 3254, 10.1074/jbc.M006701200 Console, 2003, Antennapedia and HIV transactivator of transcription (TAT) “protein transduction domains” promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans, J. Biol. Chem., 278, 35109, 10.1074/jbc.M301726200 Nakase, 2007, Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis, Biochemistry, 46, 492, 10.1021/bi0612824 Argyris, 2004, The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity, Virology, 330, 481, 10.1016/j.virol.2004.10.011 Tkachenko, 2004, Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway, J. Cell Sci., 117, 3189, 10.1242/jcs.01190 Kaplan, 2005, Cationic TAT peptide transduction domain enters cells by macropinocytosis, J. Control. Release, 102, 247, 10.1016/j.jconrel.2004.10.018 Richard, 2003, Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake, J. Biol. Chem., 278, 585, 10.1074/jbc.M209548200 El-Andaloussi, 2006, Induction of splice correction by cell-penetrating peptide nucleic acids, J. Gene Med., 8, 1262, 10.1002/jgm.950 Khalil, 2006, High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression, J. Biol. Chem., 281, 3544, 10.1074/jbc.M503202200 Gerbal-Chaloin, 2007, First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actin-network remodelling, Biol. Cell, 99, 223, 10.1042/BC20060123 Duchardt, 2007, A comprehensive model for the cellular uptake of cationic cell-penetrating peptides, Traffic, 8, 848, 10.1111/j.1600-0854.2007.00572.x Fischer, 2004, A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides, J. Biol. Chem., 279, 12625, 10.1074/jbc.M311461200 Richard, 2005, Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors, J. Biol. Chem., 280, 15300, 10.1074/jbc.M401604200 Goncalves, 2006, Structural and thermodynamic aspects of the interaction between heparan sulfate and analogues of melittin, Biochemistry, 45, 3086, 10.1021/bi052221t Magzoub, 2001, Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles, Biochim. Biophys. Acta, 1512, 77, 10.1016/S0005-2736(01)00304-2 Ziegler, 2003, Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis, Biochemistry, 42, 9185, 10.1021/bi0346805 Thoren, 2004, Membrane binding and translocation of cell-penetrating peptides, Biochemistry, 43, 3471, 10.1021/bi0360049 Thoren, 2005, Membrane destabilizing properties of cell-penetrating peptides, Biophys. Chem., 114, 169, 10.1016/j.bpc.2004.11.016 Afonin, 2006, The cell-penetrating peptide TAT(48-60) induces a non-lamellar phase in DMPC membranes, ChemPhysChem, 7, 2134, 10.1002/cphc.200600306 Mitchell, 2000, Polyarginine enters cells more efficiently than other polycationic homopolymers, J. Pept. Res., 56, 318, 10.1034/j.1399-3011.2000.00723.x Nishihara, 2005, Arginine magic with new counterions up the sleeve, Org. Biomol. Chem., 3, 1659, 10.1039/b501472g Caron, 2004, Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins, Biochem. Biophys. Res. Commun., 319, 12, 10.1016/j.bbrc.2004.04.180 Sloots, 2005, Recombinant derivatives of the human high-mobility group protein HMGB2 mediate efficient nonviral gene delivery, FEBS J., 272, 4221, 10.1111/j.1742-4658.2005.04834.x Takeuchi, 2006, Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate, ACS Chem. Biol., 1, 299, 10.1021/cb600127m Luedtke, 2003, Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginine, J. Am. Chem. Soc., 125, 12374, 10.1021/ja0360135 Wender, 2002, Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery, J. Am. Chem. Soc., 124, 13382, 10.1021/ja0275109 Goun, 2006, Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging, ChemBioChem, 7, 1497, 10.1002/cbic.200600171 Kawamura, 2006, Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells, Biochemistry, 45, 1116, 10.1021/bi051338e Kim, C.H. et al. Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma. Immunology DOI:10.1111/j.1365-2567.2007.02680.x Michiue, 2005, Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells, FEBS Lett., 579, 3965, 10.1016/j.febslet.2005.06.021 Snyder, 2005, Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides, Cancer Res., 65, 10646, 10.1158/0008-5472.CAN-05-0118 Snyder, 2004, Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide, PLoS Biol., 2, E36, 10.1371/journal.pbio.0020036 Michiue, 2005, The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction, J. Biol. Chem., 280, 8285, 10.1074/jbc.M412430200 Wang, 2004, Targeting p53 by PTD-mediated transduction, Trends Biotechnol., 22, 431, 10.1016/j.tibtech.2004.07.002 Bright, 2007, DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo, Brain Res., 1144, 146, 10.1016/j.brainres.2007.01.113 Inagaki, 2005, Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide, Circulation, 111, 44, 10.1161/01.CIR.0000151614.22282.F1 Choi, 2006, PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model, Free Radic. Biol. Med., 41, 1058, 10.1016/j.freeradbiomed.2006.06.006 Choi, 2006, Transduced Tat-alpha-synuclein protects against oxidative stress in vitro and in vivo, J. Biochem. Mol. Biol., 39, 253, 10.5483/BMBRep.2006.39.3.253 Kilic, 2005, TAT-GDNF in neurodegeneration and ischemic stroke, CNS Drug Rev., 11, 369, 10.1111/j.1527-3458.2005.tb00054.x Kilic, 2006, TAT fusion proteins against ischemic stroke: current status and future perspectives, Front. Biosci., 11, 1716, 10.2741/1917 Bullok, 2006, Permeation peptide conjugates for in vivo molecular imaging applications, Mol. Imaging, 5, 1, 10.2310/7290.2006.00001 Aussedat, 2006, Quantification of the efficiency of cargo delivery by peptidic and pseudo-peptidic Trojan carriers using MALDI-TOF mass spectrometry, Biochim. Biophys. Acta, 1758, 375, 10.1016/j.bbamem.2006.01.012 Loison, 2005, A ubiquitin-based assay for the cytosolic uptake of protein transduction domains, Mol. Ther., 11, 205, 10.1016/j.ymthe.2004.10.010